SCHEMBL22300290

SCHEMBL22300290

C=C(C(C)C)N1CCC(c2ccccc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.56
▸ KCNH2 Q12809 1/20 0.56
▸ SLC18A3 Q16572 8/20 0.48
▸ DRD2 P14416 1/20 0.46
▸ LIPE Q05469 2/20 0.46
▸ NAMPT P43490 1/20 0.44
▸ CYP2D6 P10635 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ BACE1 P56817 1/20 0.43
▸ ADAMTS5 Q9UNA0 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13588778 0.80 KCNH2 (0.64) HRH3KCNH2LIPENAMPTSMN1; SMN2
SCHEMBL20005005 0.78 HRH3 (0.48) HRH3KCNH2SLC18A3DRD2LIPE
SCHEMBL13588795 0.78 HRH3 (0.61) HRH3KCNH2LIPENAMPTSMN1; SMN2
SCHEMBL25447855 0.76 KCNH2 (0.59) HRH3KCNH2CYP2C9
SCHEMBL22537843 0.75 HRH3 (0.55) HRH3KCNH2SLC18A3LIPENAMPT
SCHEMBL16886312 0.74 RAB9A (0.58) HRH3KCNH2NAMPTSMN1; SMN2TSHR
SCHEMBL15045186 0.74 KCNH2 (0.61) HRH3KCNH2LIPENAMPTADAMTS5
SCHEMBL11123314 0.74 KCNH2 (0.56) HRH3KCNH2SLC18A3SMN1; SMN2SIGMAR1
SCHEMBL2661616 0.74 KCNH2 (0.56) HRH3KCNH2SLC18A3DRD2CYP2D6
SCHEMBL1473424 0.74 QDPR (0.61) HRH3KCNH2SLC18A3SMN1; SMN2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020160321-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING FIBROSIS YALE UNIVERSITY (US) 2020-08-06 — — WO disclosed
Send feedback